SC 13G/A: BIODESIX INC

AI Summary

SC 13G/A filing by BIODESIX INC.

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• formsc13ga.htm (SC 13G/A) — 91KB
• 0001493152-24-044966.txt ( ) — 93KB

From the Filing

SC 13G/A 1 formsc13ga.htm United Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Biodesix, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 09075X108 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 09075X108 Schedule 13G/A Page 1 of 6 1 Names of Reporting Persons IND Funding LLC 2 Check the Appropriate Box if a Member of a Group (a) (b) 3 SEC Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 6 Shared Voting Power 2,180,514 7 Sole Dispositive Power 0 8 Shared Dispositive Power 2,180,514 9 Aggregate Amount Beneficially Owned by Each Reporting Person 2,180,514 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares 11 Percent of Class Represented by Amount in Row 9 1.5% 12 Type of Reporting Person OO CUSIP No. 09075X108 Schedule 13G/A Page 2 of 6 1 Names of Reporting Persons Life Sciences Alternative Funding LLC 2 Check the Appropriate Box if a Member of a Group (a) (b) 3 SEC Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With 5 Sole Voting Power 0 6 Shared Voting Power 2,180,514 7 Sole Dispositive Power 0 8 Shared Dispositive Power 2,180,514 9 Aggregate Amount Beneficially Owned by Each Reporting Person 2,180,514 10 Check if the Aggregate Amount in Row (9) Excludes Certain Shares 11 Percent of Class Represented by Amount in Row 9 1.5% 12 Type of Reporting Person OO CUSIP No. 09075X108 Schedule 13G/A Page 3 of 6 ITEM 1. (a) Name of Issuer: Biodesix, Inc. (the “Issuer”). (b) Address of Issuer’s Principal Executive Offices: 919 West Dillon Rd, Louisville, Colorado 80027. ITEM 2. (a) Name of Person Filing: This together the “Reporting Persons”). (b) Address or Principal Business Office: The NY 10153. (c) Citizenship of each Reporting Person is: Each of the Reporting Persons is organized under the laws of the State of Delaware. (d) Title of Class of Securities: Common Stock, par value $0.001 per share (“Common Stock”). (e) CUSIP Number: 09075X108 ITEM 3. Not applicable. CUSIP No. 09075X108 Schedule 13G/A Page 4 of 6 ITEM 4. Ownership. (a-c) The date hereof, based upon 145,467,295 shares of Common Stock outstanding as of October 25, 2024, as disclosed in the quarterly report on Form 10-Q as filed by the Issuer with the Securities and Exchange Commission on November 1, 2024. Reporting Person Amount beneficially owned Percent of class: Sole power to vote or to direct the vote: Shared power to vote or to direct the vote: Sole power to dispose or to direct the disposition of: Shared power to dispose or to direct the disposition of: IND Funding LLC 2,180,514 1.5 % 0 2,180,514 0 2,180,514 Life Sciences Alternative Funding LLC 2,180,514 1.5 % 0 2,180,514 0 2,180,514 The shares reported herein consists of (a) 1,887,791 shares of Common Stock held by IND Funding LLC and (b) 292,723 shares of Common Stock held by Life Sciences Alternative Funding LLC. ITEM 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following: ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. ITEM 8. Identification and Classification of Members of the Group. Not a

View Full Filing

View this SC 13G/A filing on SEC EDGAR